• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中的副肿瘤综合征:综述

Paraneoplastic syndromes in hepatocellular carcinoma: a review.

作者信息

Ong Yuki, Huey Cheong Wei Terence, Shelat Vishalkumar Girishchandra

机构信息

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Hepato-Pancreatico-Biliary Surgery, Department of Surgery, Tan Tock Seng Hospital, Singapore, Singapore.

出版信息

Expert Rev Gastroenterol Hepatol. 2022 May;16(5):449-471. doi: 10.1080/17474124.2022.2085556. Epub 2022 Jun 8.

DOI:10.1080/17474124.2022.2085556
PMID:35649187
Abstract

INTRODUCTION

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and a significant proportion (20-40%) of patients with HCC develop paraneoplastic syndromes (PNS). Despite this, there is a paucity of clinical evidence regarding PNS in HCC.

AREAS COVERED

A systematic search was performed to identify relevant case studies regarding PNS in HCC. Another search was conducted to identify studies that evaluated the impact of PNS on survival outcomes in HCC. Since there are currently no international guidelines for PNS in HCC, this review aims to provide comprehensive summaries and recommendations of PNS in HCC, including the pathophysiology, clinical features, diagnostic approach, and management, so that clinicians remain guided in caring for HCC patients with PNS. In general, PNS are associated with poorer survival outcomes and negative prognostic markers of HCC.

EXPERT OPINION

The presence of PNS has a significant influence on survival rates and clinical outcomes of patients with HCC. They contribute to significant morbidity, influencing patients' quality of life and fitness for curative and palliative therapies. Therefore, it is paramount for PNS to be integrated into routine investigations after diagnosing HCC to guide further management and prognostication of the disease.

摘要

引言

肝细胞癌(HCC)是全球最常见的癌症之一,相当一部分(20%-40%)HCC患者会发生副肿瘤综合征(PNS)。尽管如此,关于HCC中PNS的临床证据却很匮乏。

涵盖领域

进行了系统检索以确定有关HCC中PNS的相关病例研究。还进行了另一项检索以确定评估PNS对HCC生存结局影响的研究。由于目前尚无关于HCC中PNS的国际指南,本综述旨在全面总结和推荐HCC中的PNS,包括其病理生理学、临床特征、诊断方法和管理,以便临床医生在护理患有PNS的HCC患者时仍能得到指导。一般而言,PNS与HCC较差的生存结局和不良预后标志物相关。

专家观点

PNS的存在对HCC患者的生存率和临床结局有重大影响。它们会导致严重的发病率,影响患者的生活质量以及接受根治性和姑息性治疗的适用性。因此,在诊断HCC后将PNS纳入常规检查以指导疾病的进一步管理和预后至关重要。

相似文献

1
Paraneoplastic syndromes in hepatocellular carcinoma: a review.肝细胞癌中的副肿瘤综合征:综述
Expert Rev Gastroenterol Hepatol. 2022 May;16(5):449-471. doi: 10.1080/17474124.2022.2085556. Epub 2022 Jun 8.
2
Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.肝癌患者副肿瘤综合征的频率及其预后影响。
Eur J Gastroenterol Hepatol. 2022 Jul 1;34(7):769-773. doi: 10.1097/MEG.0000000000002341. Epub 2021 Dec 30.
3
Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.肝细胞癌中的副肿瘤综合征、流行病学及生存率:一项七年回顾性研究
Medicina (Kaunas). 2024 Mar 28;60(4):552. doi: 10.3390/medicina60040552.
4
Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.副肿瘤综合征在肝细胞癌中的预后作用及意义
Am Surg. 2014 Feb;80(2):191-6.
5
Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.肝细胞癌副肿瘤综合征的流行病学与预后
ISRN Oncol. 2013 Dec 11;2013:684026. doi: 10.1155/2013/684026. eCollection 2013.
6
[The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].[肝细胞癌患者副肿瘤综合征的发生率及临床意义]
Korean J Hepatol. 2005 Sep;11(3):275-83.
7
Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.肝细胞癌患者高胆固醇血症、低血糖症、红细胞增多症和高钙血症的表现:两例报告
J Gastroenterol Hepatol. 1999 Aug;14(8):807-10. doi: 10.1046/j.1440-1746.1999.01955.x.
8
[A case of hepatocellular carcinoma with paraneoplastic hypercholesterolemia, thrombocytosis and hypoglycemia].
Nihon Shokakibyo Gakkai Zasshi. 2007 Aug;104(8):1231-5.
9
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.伴有副肿瘤综合征的肝细胞癌患者的临床特征与预后
Hepatogastroenterology. 2002 Sep-Oct;49(47):1315-9.
10
Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.纤维板层肝细胞癌的临床特征和手术治疗效果:单中心回顾性分析。
World J Surg Oncol. 2020 May 12;18(1):93. doi: 10.1186/s12957-020-01855-2.

引用本文的文献

1
Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer.肝癌分子认识、早期检测及靶向治疗的进展与挑战
World J Hepatol. 2025 Jan 27;17(1):102273. doi: 10.4254/wjh.v17.i1.102273.
2
Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.肝细胞癌中的副肿瘤综合征、流行病学及生存率:一项七年回顾性研究
Medicina (Kaunas). 2024 Mar 28;60(4):552. doi: 10.3390/medicina60040552.
3
Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. A Systematic Review and Meta-analysis.
肝细胞癌的副肿瘤性皮肤表现。一项系统评价和Meta分析。
J Cancer. 2024 Jan 1;15(4):1021-1029. doi: 10.7150/jca.88931. eCollection 2024.
4
miR-4270 suppresses hepatocellular carcinoma progression by inhibiting DNMT3A-mediated methylation of HGFAC promoter.miR-4270 通过抑制 DNMT3A 介导的 HGFAC 启动子甲基化抑制肝细胞癌进展。
PeerJ. 2023 Dec 5;11:e16566. doi: 10.7717/peerj.16566. eCollection 2023.
5
Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen.C57BL/6 小鼠经放射和免疫细胞因子免疫治疗方案治愈 B78 黑色素瘤后的抗体全景。
Front Immunol. 2023 Nov 23;14:1221155. doi: 10.3389/fimmu.2023.1221155. eCollection 2023.
6
Chronic inflammatory demyelinating polyneuropathy caused by hepatocellular carcinoma.由肝细胞癌引起的慢性炎症性脱髓鞘性多发性神经病。
BMJ Case Rep. 2023 Feb 10;16(2):e251770. doi: 10.1136/bcr-2022-251770.
7
The role of platelet-lymphocyte ratio in hepatocellular carcinoma: a valuable prognostic marker.血小板-淋巴细胞比值在肝细胞癌中的作用:一种有价值的预后标志物。
Transl Cancer Res. 2022 Dec;11(12):4231-4234. doi: 10.21037/tcr-22-2343.